Insider Activity of Riley Jennifer
According to the SEC Form 4 filings, Riley Jennifer, being in a position of
- Chief Strategy Officer at Avalo Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 2655 shares for $52,012,over all time since 2026-08-11, has bought 0 shares, and sold 2655 shares for $52,012.
Biography of Riley Jennifer
No biography is available at this moment.